“Catalpol alleviates the lipopolysaccharide-induced inflammatory response of BV2 cells”, Bangladesh J Pharmacol, vol. 19, no. 3, pp. 88–94, Dec. 2024, doi: 10.3329/bjp.v19i3.76556.